Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (491-500 of 555) with videos related to

Pageof 56
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicityDavid A Wohl, Christopher D Pilcher, Scott Evans, et al.
Molekuliarnaia Biologiia|January 15, 2009
[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer]E A Anedchenko, A A Dmitriev, G S Krasnov, et al.
Oncogene|July 12, 2011
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinomaE W L Law, A K L Cheung, V I Kashuba, et al.
Pharmaceutics|February 24, 2024
Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEPTalisa S Kinsale, Mackenzie L Cottrell, Linying Li, et al.
The Journal of Infectious Diseases|October 3, 2017
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral TherapyDavid M Asmuth, Corbin G Thompson, Tae-Wook Chun, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivoTwana Alkasalias, Andrey Alexeyenko, Katharina Hennig, et al.
Pharmacotherapy|July 24, 2019
Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus InfectionBani Tamraz, Lori Reisner, Audrey L French, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Journal of Virology|June 22, 2018
Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant MacaquesEgidio Brocca-Cofano, Cuiling Xu, Katherine S Wetzel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2025
Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV preventionThy Le, Isabella C Young, Jasmine L King, et al.
Pageof 56

Showing results (491-500 of 555) with videos related to

Sort By:
Pageof 56
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicityDavid A Wohl, Christopher D Pilcher, Scott Evans, et al.
Molekuliarnaia Biologiia|January 15, 2009
[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer]E A Anedchenko, A A Dmitriev, G S Krasnov, et al.
Oncogene|July 12, 2011
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinomaE W L Law, A K L Cheung, V I Kashuba, et al.
Pharmaceutics|February 24, 2024
Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEPTalisa S Kinsale, Mackenzie L Cottrell, Linying Li, et al.
The Journal of Infectious Diseases|October 3, 2017
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral TherapyDavid M Asmuth, Corbin G Thompson, Tae-Wook Chun, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivoTwana Alkasalias, Andrey Alexeyenko, Katharina Hennig, et al.
Pharmacotherapy|July 24, 2019
Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus InfectionBani Tamraz, Lori Reisner, Audrey L French, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Journal of Virology|June 22, 2018
Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant MacaquesEgidio Brocca-Cofano, Cuiling Xu, Katherine S Wetzel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2025
Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV preventionThy Le, Isabella C Young, Jasmine L King, et al.
Pageof 56